We are independent & ad-supported. We may earn a commission for purchases made through our links.

Advertiser Disclosure

Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.

How We Make Money

We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently from our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

What Is Antihemophilic Factor?

By Jillian O Keeffe
Updated Mar 03, 2024
Our promise to you
TheHealthBoard is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At TheHealthBoard, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

Human blood naturally contains substances that help the blood clot at an injury. Antihemophilic factor is one of these chemicals, and doctors can use commercially available forms of it to help people who have problems with clotting. Sources of medical antihemophilic factor include human blood donations and genetically engineered cell culture.

In the body, antihemophilic factor is only one of the substances that the body needs to produce an efficient blood clot. It is also known as Factor VIII. Some people do not produce Factor VIII, and these people suffer from classic hemophilia, a disease where the body bleeds uncontrollably from even minor injuries. Another disease called Von Willebrand disease causes sufferers to have antihemophilic factor that does not work properly.

People who suffer from these diseases can often benefit from a regular dose of antihemophilic factor. It helps the blood to clot normally, and reduces the risk of death from severe bleeding. A patient may either receive an injection of the chemical, or he or she may receive an infusion into a vein that takes less than ten minutes.

Blood donors have antihemophilic factor circulating in the blood. Scientists can extract this substance from donated blood and give it to another person who needs it. One major problem with human donated antihemophilic factor is that the product carries a risk of contamination by human pathogens, such as the human immunodeficiency virus (HIV.)

Another option that does not carry this risk is an artificially produced form of antihemphilic factor. In this case, a drug company genetically engineers cells with the gene that codes for the substance, and harvests the factor from the cells. This form of the medication has the same effects inside the body as the form that comes from human blood donations.

Both the recombinant and natural forms of the chemical cause the same side effects. These may include dizzy spells, excessive tiredness and headaches. A patient may also suffer from an irritated throat and stomach problems.

Occasionally, antihemophilic factor can cause allergic reactions in recipients. This manifests itself in symptoms like skin hives and problems breathing. Other serious side effects include unexplained bruises or bleeding. When a patient receives an infusion into the vein, he or she may also have problems with the tube that delivers the chemical into the body. Signs that the catheter location is infected include swelling, pain, and heat at the site of insertion.

TheHealthBoard is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.

Discussion Comments

TheHealthBoard, in your inbox

Our latest articles, guides, and more, delivered daily.

TheHealthBoard, in your inbox

Our latest articles, guides, and more, delivered daily.